As filed with the Securities and Exchange Commission on April 2, 2026
Registration No. 333-294719
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Adagio Medical Holdings, Inc.
(Exact name of Registrant as specified in its charter)
| Delaware | 99-1151466 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
26051 Merit Circle, Suite 102 Laguna Hills, California |
92653 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
Adagio Medical Holdings, Inc. 2024 Equity Incentive Plan
(Full Title of the Plans)
Todd Usen
Chief Executive Officer
Adagio Medical Holdings, Inc.
26051 Merit Circle, Suite 102
Laguna Hills, California 92653
(949) 348-1188
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Eric Blanchard
Paul Alexander
Cooley LLP
500 Boylston Street, 14th Floor
Boston, MA 02116
Tel: (617) 937-2300
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ¨ | Accelerated filer | ¨ | ||
| Non-accelerated filer | x | Smaller reporting company | x | ||
| Emerging growth company | x |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
EXPLANATORY NOTE
This Post-Effective Amendment No. 1 to the Registration Statement on Form S-8 (File No. 333-294719), originally filed by Adagio Medical Holdings, Inc. (the "Registrant") with the Securities and Exchange Commission on March 30, 2026, is being filed solely to correct Exhibit 23.1, the Consent of Independent Registered Public Accounting Firm. The original filing mistakenly included a version of the consent with an incorrect date for the report of WithumSmith + Brown, PC with respect to the Registrant’s consolidated financial statements included in the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2025. No other changes have been made to the Registration Statement.
Item 8. Exhibits.
Reference is made under this Item 8 to the exhibit index included in this Registration Statement.
Exhibit Index
* Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Laguna Hills, State of California, on this 2nd day of April, 2026.
| Adagio Medical Holdings, Inc. | ||
| By: | /s/ Todd Usen | |
| Todd Usen | ||
| Chief Executive Officer |
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.
| Signature | Title | Date | ||
/s/ Todd Usen |
Chief Executive Officer and Director (Principal Executive Officer) |
April 2, 2026 | ||
| Todd Usen | ||||
| /s/ Deborah Kaster | Chief Financial Officer | April 2, 2026 | ||
| Deborah Kaster | (Principal Financial and Accounting Officer) | |||
| * | Director | April 2, 2026 | ||
| James L. Cox | ||||
| * | Director | April 2, 2026 | ||
| Orly Mishan | ||||
| * | Director | April 2, 2026 | ||
| Keyvan Mirsaeedi-Farahani | ||||
| * | Director | April 2, 2026 | ||
| Sean Salmon | ||||
| * | Director | April 2, 2026 | ||
| Timothy Moran | ||||
| * | Director | April 2, 2026 | ||
| Sandra Gardiner | ||||
| /s/ Todd Usen | ||||
| Todd Usen | ||||
| Attorney-in-fact |